Bethan Lang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bethan Lang has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Angela Vincent
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
7 shared publications Angela Vincent
Neurosciences Group and Department of Clinical Neurology, Oxford University, Oxford, United Kingdom
4 shared publicationsJohn Newsom‐Davis
Neurosciences Group and Department of Clinical Neurology, Oxford University, Oxford, United Kingdom
2 shared publications- Leslie Jacobson
From the Department of Basic and Clinical Neuroscience (E.C., A. Vernon), Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute; Medical Research Council Centre for Neurodevelopmental Disorders (E.C., A. Vernon), King's College London; Nuffield Department of Clinical Neurosciences (L.J., A. Vincent), University of Oxford; and UCB Pharma (A.S., B.S.), Slough, United Kingdom
2 shared publications Russell C. Dale
2 shared publicationsAgata Polizzi
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
1 shared publication
Latest Publications
- 1 March 2017
- Published by Elsevier in The Lancet Psychiatry
- Vol. 4 (3) , 187-188
Serum neuronal cell-surface antibodies in first-episode psychosis–Authors' reply
- 1 March 2017
- Published by Elsevier in The Lancet Psychiatry
- Vol. 4 (3) , 187-188
Serum neuronal cell-surface antibodies in first-episode psychosis–Authors' reply
- 1 February 2017
- Published by Elsevier in The Lancet
- Vol. 389, S18
Maternal CASPR2 antibodies and neurodevelopmental disorders in the offspring: epidemiological findings and an animal model
- 1 February 2017
- Published by Elsevier in The Lancet
- Vol. 389, S18
Maternal CASPR2 antibodies and neurodevelopmental disorders in the offspring: epidemiological findings and an animal model
- 22 December 2016
- Published by Wiley in Muscle & Nerve
- Vol. 56 (5) , 998-1000
Paraneoplastic cerebellar degeneration and lambert‐eaton myasthenia in a patient with merkel cell carcinoma and voltage‐gated calcium channel antibodies
Introduction Merkel cell carcinoma is a rare cutaneous, aggressive tumor. Although it shares many neuroendocrine features with small cell lung carcinoma, it has only occasionally been reported with paraneoplastic neurological syndromes. Methods A healthy 67‐year‐old man developed acute ataxia, vertigo, and nausea. Subsequently he also developed dysarthria, diplopia, xerostomia, fatigability and progressive anorexia. He underwent a full diagnostic workup and was found to have a high titer of voltage‐gated calcium channel antibodies in serum and cerebrospinal fluid, neurophysiological findings compatible with Lambert‐Eaton myasthenia and neurological signs compatible with cerebellar degeneration. Results A positron emission tomography study revealed a hypermetabolic lesion in the axilla, subsequently biopsied and consistent with Merkel cell carcinoma. Conclusions In most previous reports, neurological symptoms preceded the Merkel cell carcinoma diagnosis, and the primary localization was in lymph nodes. This tumor should be considered in patients with paraneoplastic syndrome, and particularly Lambert‐Eaton myasthenia after exclusion of small cell lung carcinoma. Muscle Nerve 56: 998–1000, 2017
- 22 December 2016
- Published by Wiley in Muscle & Nerve
- Vol. 56 (5) , 998-1000
Paraneoplastic cerebellar degeneration and lambert‐eaton myasthenia in a patient with merkel cell carcinoma and voltage‐gated calcium channel antibodies
Introduction Merkel cell carcinoma is a rare cutaneous, aggressive tumor. Although it shares many neuroendocrine features with small cell lung carcinoma, it has only occasionally been reported with paraneoplastic neurological syndromes. Methods A healthy 67‐year‐old man developed acute ataxia, vertigo, and nausea. Subsequently he also developed dysarthria, diplopia, xerostomia, fatigability and progressive anorexia. He underwent a full diagnostic workup and was found to have a high titer of voltage‐gated calcium channel antibodies in serum and cerebrospinal fluid, neurophysiological findings compatible with Lambert‐Eaton myasthenia and neurological signs compatible with cerebellar degeneration. Results A positron emission tomography study revealed a hypermetabolic lesion in the axilla, subsequently biopsied and consistent with Merkel cell carcinoma. Conclusions In most previous reports, neurological symptoms preceded the Merkel cell carcinoma diagnosis, and the primary localization was in lymph nodes. This tumor should be considered in patients with paraneoplastic syndrome, and particularly Lambert‐Eaton myasthenia after exclusion of small cell lung carcinoma. Muscle Nerve 56: 998–1000, 2017
- 7 October 2014
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 46 (01) , 013-019
Epilepsy and Autoimmunity in Pediatric Patients
Our aim was to determine the presence and possible role of autoantibodies in epileptic patients with an undetermined etiology. Eighty epilepsy patients, who were referred to the Pediatric Neurology Department at Ankara University between November 2011 and April 2012, were enrolled in the study. Antinuclear antibodies (ANA), anticardiolipin IgG, antiphospholipid, antithyroid peroxidase, paraneoplastic, glutamic acid decarboxylase (GAD), and N-methyl-d-aspartate (NMDA) receptor antibodies were studied in our university laboratory. In addition, NMDA receptor (NMDAR), voltage-gated potassium channel (VGKC)-complex, leucine-rich, glioma inactivated 1 (LGI1) and contactin-associated protein 2 (CASPR2) antibodies were studied at the Oxford University Immunology Laboratory. The study included 35 girls (44%) and 45 boys (56%) with a mean symptom age of 8.6 ± 4.53 years. ANA was detected in 15 (18.8%), antiphospholipid Ab in 3 (3.75%), anticardiolipin Ab in 1 (1.25%), and antithyroid peroxidase in 3 (3.75%) epileptic patients. In addition, anti-GAD Ab was detected in 7 (8.75%), anti-Yo Ab in 3 (3.75%), and anti-Ma2 in 3 (3.75%) epileptic patients. Anti-VGKC was positive in 13 (16.25%) epileptic patients. We performed a pioneer study to investigate the association between autoimmunity and pediatric epilepsy and we conclude that autoimmunity should be considered in epileptic patients with an undetermined etiology.
- 7 October 2014
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 46 (01) , 013-019
Epilepsy and Autoimmunity in Pediatric Patients
Our aim was to determine the presence and possible role of autoantibodies in epileptic patients with an undetermined etiology. Eighty epilepsy patients, who were referred to the Pediatric Neurology Department at Ankara University between November 2011 and April 2012, were enrolled in the study. Antinuclear antibodies (ANA), anticardiolipin IgG, antiphospholipid, antithyroid peroxidase, paraneoplastic, glutamic acid decarboxylase (GAD), and N-methyl-d-aspartate (NMDA) receptor antibodies were studied in our university laboratory. In addition, NMDA receptor (NMDAR), voltage-gated potassium channel (VGKC)-complex, leucine-rich, glioma inactivated 1 (LGI1) and contactin-associated protein 2 (CASPR2) antibodies were studied at the Oxford University Immunology Laboratory. The study included 35 girls (44%) and 45 boys (56%) with a mean symptom age of 8.6 ± 4.53 years. ANA was detected in 15 (18.8%), antiphospholipid Ab in 3 (3.75%), anticardiolipin Ab in 1 (1.25%), and antithyroid peroxidase in 3 (3.75%) epileptic patients. In addition, anti-GAD Ab was detected in 7 (8.75%), anti-Yo Ab in 3 (3.75%), and anti-Ma2 in 3 (3.75%) epileptic patients. Anti-VGKC was positive in 13 (16.25%) epileptic patients. We performed a pioneer study to investigate the association between autoimmunity and pediatric epilepsy and we conclude that autoimmunity should be considered in epileptic patients with an undetermined etiology.
- 25 February 2014
- Published by Elsevier in The Lancet
- Vol. 383, S111
Autoantibodies to the N-methyl-D-aspartate receptor and seizure susceptibility in mice
- 25 February 2014
- Published by Elsevier in The Lancet
- Vol. 383, S111
Autoantibodies to the N-methyl-D-aspartate receptor and seizure susceptibility in mice
- 1 January 2010
- Published by Springer Nature
- p. 153-164
Autoimmune Epilepsy
- 30 June 2009
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 9 (3) , 336-340
Autoimmune disorders of the neuromuscular junction
- 30 June 2009
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 9 (3) , 336-340
Autoimmune disorders of the neuromuscular junction
- Open Access
- 31 December 2006
- Published by Elsevier in Molecular Therapy
- Vol. 13, S349
905. The Use of Gene Immunisation To Study the Role of Antibodies to Voltage Gated Potassium Channels in Neuroimmunological Disease
- 31 December 2006
- Published by Elsevier in Molecular Therapy
- Vol. 13, S349
Open Access905. The Use of Gene Immunisation To Study the Role of Antibodies to Voltage Gated Potassium Channels in Neuroimmunological Disease
- 1 March 2006
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 2 (2) , 293-307
Autoantibodies in neuromuscular autoimmune disorders
Partly because they are vital but vulnerable, neuromuscular receptors/ion channels are frequently the focus of attack in autoimmune diseases. With such well defined targets and patient subgroups, and with such clear antibody-mediated pathogeneses, these diseases offer excellent scope for highly specific diagnostic tests, which already help to point patients towards optimal treatments. This review focuses on the autoantibodies and their detection, and briefly considers prospects for novel therapeutic approaches. These disorders have also proved fertile ground for detailed studies on pathogenic mechanisms. Moreover, it is hoped that the distinct patient subgroups and the characteristic tumor associations therein will hold valuable clues to pathways of autoimmunization.
- 1 March 2006
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 2 (2) , 293-307
Autoantibodies in neuromuscular autoimmune disorders
Partly because they are vital but vulnerable, neuromuscular receptors/ion channels are frequently the focus of attack in autoimmune diseases. With such well defined targets and patient subgroups, and with such clear antibody-mediated pathogeneses, these diseases offer excellent scope for highly specific diagnostic tests, which already help to point patients towards optimal treatments. This review focuses on the autoantibodies and their detection, and briefly considers prospects for novel therapeutic approaches. These disorders have also proved fertile ground for detailed studies on pathogenic mechanisms. Moreover, it is hoped that the distinct patient subgroups and the characteristic tumor associations therein will hold valuable clues to pathways of autoimmunization.
- Open Access
- 1 January 2005
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (1) , 117-121
Antibodies to Voltage‐Gated Calcium Channels in Children with Falciparum Malaria
Falciparum malaria can affect the central nervous system (CNS), causing neurological dysfunction and sequelae. The pathophysiology of these complicat
- 1 January 2005
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (1) , 117-121
Open AccessAntibodies to Voltage‐Gated Calcium Channels in Children with Falciparum Malaria
Falciparum malaria can affect the central nervous system (CNS), causing neurological dysfunction and sequelae. The pathophysiology of these complicat